Zecken-übertragene Infektionen

Zecken-übertragene Infektionen - Frühsommer-Meningoenzephalitis - Rickettsien - Borreliose - Zeckenstichfieber

tick-borne disease - tick-borne encephalitis - rickettsia - Lyme borreliosis - tick-borne spotted fever

Literatur

• 1 Aberer E, Fingerle V, Wutte N, Fink-Puches R, Cerroni L. Within European margins.  Lancet. 2011;  377 178
• 2 Cerar D, Cerar T, Ruzic-Sabljic E, Wormser G P, Strle F. Subjective symptoms after treatment of early Lyme disease.  Am J Med. 2010;  123 79-86
• 3 Cerar T, Ogrinc K, Strle F, Ruzic-Sabljic E. Humoral immune responses in patients with Lyme neuroborreliosis.  Clin Vaccine Immunol. 2010;  17 645-650
• 4 Dobler G, Wolfel R. Typhus and other rickettsioses: emerging infections in Germany.  Dtsch Arztebl Int. 2009;  106 348-354
• 5 Fomsgaard A, Christiansen C, Bodker R. First identification of tick-borne encephalitis in Denmark outside of Bornholm, August 2009.  Euro Surveill. 2009;  14 19325
• 6 Grgic-Vitek M, Avsic-Zupanc T, Klavs I. Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis.  Vaccine. 2010;  28 7396-7400
• 7 Haglund M. Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE).  Int J Med Microbiol. 2002;  291 Suppl 33 50-54
• 8 Heinz F X, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis.  Vaccine. 2007;  25 7559-7567
• 9 Jaaskelainen A E, Tikkakoski T, Uzcategui N Y. et al . Siberian subtype tickborne encephalitis virus, Finland.  Emerg Infect Dis. 2006;  12 1568-1571
• 10 Kunze U. Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE).  Vaccine. 2011;  29 1355-1356
• 11 Lakos A. Tick-borne lymphadenopathy – a new rickettsial disease?.  Lancet. 1997;  350 1006
• 12 Liebisch A. Zur Überträgerökologie der Zeckenenzephalitis in der Bundesrepublik Deutschland. Sitzungsberichte der Heidelberger Akademie der Wissenschaften. 1978: 112-121
• 13 Ljostad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosiss.  Eur J Neurol. 2010;  17 118-123
• 14 Ljostad U, Skogvoll E, Eikeland R. et al . Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.  Lancet Neurol. 2008;  7 690-695
• 15 Mygland A, Ljostad U, Fingerle V. et al . EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.  Eur J Neurol. 2010;  17 8-16
• 16 O’Connell S. Lyme borreliosis: current issues in diagnosis and management.  Curr Opin Infect Dis. 2010;  23 231-235
• 17 Pluta S, Tewald F, Hartelt K. et al . Rickettsia slovaca in Dermacentor marginatus ticks, Germany.  Emerg Infect Dis. 2009;  15 2077-2078
• 18 Raoult D, Lakos A, Fenollar F. et al . Spotless rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks.  Clin Infect Dis. 2002;  34 1331-1336
• 19 Raoult D, Roux V. Rickettsioses as paradigms of new or emerging infectious diseases.  Clin Microbiol Rev. 1997;  10 694-719
• 20 Rehacek J. Rickettsia slovaca, the organism and its ecology.  Acta SC Nat Brno. 1984;  18 1-50
• 21 Stanek G, Fingerle V, Hunfeld K P. et al . Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.  Clin Microbiol Infect. 2011;  17 69-79
• 22 Stanek G, Reiter M. The expanding Lyme Borrelia complex. Clinical significance of genomic species?.  Clin Microbiol Infect. 2011;  17 487-493
• 23 Stanek G, Strle F. Lyme borreliosis: a European perspective on diagnosis and clinical management.  Curr Opin Infect Dis. 2009;  22 450-454
• 24 STIKO . Empfehlungen der Ständigen Impfkommission am Robert Koch-Institut / Stand: Juli 2010.  Epidem Bull. 2010;  279-298
• 25 Weinberger B, Keller M, Fischer K H. et al . Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50 – 90 years.  Vaccine. 2010;  28 3511-3515
• 26 Wölfel S, Schmoldt S, Rieg S, Georgii E, Kern W V, Dobler G. First desciption of TIBOLA (tick borne lymphadenopathy) in Germany.  Poster, 12. Biodefense Tagung, München 2009.